Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Vorapaxar in the secondary prevention of atherothrombotic events
Internal Medicine
Cardiovascular Research Priority Area
Research output
:
Contribution to journal
›
Article
›
peer-review
846
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Vorapaxar in the secondary prevention of atherothrombotic events'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Vorapaxar
100%
Placebo
55%
Heart Infarction
33%
Death
33%
Brain Hemorrhage
33%
Cerebrovascular Accident
33%
Proteinase Activated Receptor 1
33%
Thrombin
22%
Bleeding
22%
Atherosclerosis
11%
Peripheral Occlusive Artery Disease
11%
Brain Ischemia
11%
Ischemia
11%
Antithrombocytic Agent
11%
Proteinase Activated Receptor
11%